Who we are
As a start-up in the neurotech space, we at Bottneuro aim to improve the lives of people suffering from cognitive disorders through the advancement of personalised, non-invasive, home-based transcranial electrical stimulation (tES).
Our Team
Inspiration comes of working every day - but only with a positive mindset. I want to ensure that technology simplifies the everyday life of all those who are particularly challenged by health issues.
Dr. Bekim Osmani
CEO
I am convinced that by expanding our knowledge about neurodegenerative diseases we are able to limit and counteract harmful disease progression.
Dr. Alois C. Hopf
CSO
At Bottneuro, I have taken on the challenge of digital therapy for neurodegenerative diseases, helping to expand the technology and push it towards personalised treatment.
Mahyar Joodaki
Head of Digital Therapeutics
I am fascinated about psychology and neuroscience to better understand human behavior.
Annina Ruffner
Client Service Manager
Prof. Dr. Raphael Guzman
Co-Founder and Clinical Advisor
Prof. Dr. phil. Andreas Monsch
Clinical Advisor
Prof. Dr. Emiliano Santarnecchi
Scientific Advisor
Dr. Antonella Santuccione Chadha
Clinical Advisor
Prof. Christoph Michel
Scientific Advisor
Lucie Bréchet
Scientific Advisor
Patrick Griss
Advisor to the Board
Sophie Lamparter
Advisor US Market
Guido Mesmer
Financial and M&A Advisor
David Eiler
Regulatory and QMS
Thomas Hefti, PhD
Commercial Advisor
Dr. Bekim Osmani
CEO
Rolf Wildermuth
Chairman of the Board, Former CEO Medtronic CH
Pascal Brenneisen
Board Member, Former CEO Novartis CH
Dr. Tino Töpper
Board Member, Advisor
Our Partner Clinics
Priority Access Program Partner
Dr. Filip Barinka
Altersneurologie am Swiss
Clinical Neuro Science Institute (SCNSI)
Bürglistrasse 29
8002 Zürich
Priority Access Program Partner
Bellevue Medical Group AG
Neurocenter Bellevue
Theaterstrasse 8
8001 Zürich
Priority Access Program Partner
Fachklinik KopfwehZentrum Hirslanden
Forchstrasse 424,
8702 Zollikon,
Switzerland